A newly FDA-approved heart valve device has been implanted in a patient at Vanderbilt Health. The device, known as the M3, is a transseptal transcatheter mitral valve replacement. A Brentwood woman was the first to receive this device at the hospital.

The procedure is described as quick and painless, offering new options for high-risk patients. It may allow patients who otherwise wouldn't have options to live a healthier, longer life.

Further details about the procedure and the device are available from the source. Vanderbilt Health has begun implantations and has a list of patients waiting for the procedure.